Please login to read the full article.
Scrip Regulatory Affairs
EDQM updates biologicals agenda for European Pharmacopoeia
20 February 2012
Vibha Sharma
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- US PDUFA V deal adds 60-day cushion for new drug, biologic reviews
- US Senate leaders caution against 'non-relevant' FDA drug, device user fee amendments
- GHTF successor IMDRF to expand membership; shortlists work priorities at inaugural meeting
- US lawmakers introduce generics, biosimilars user fees bill
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
